Journal of Korean Society of Health-System Pharmacists

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN    pISSN

Table. 4.

Table. 4.

Early treatment response of empirical antibiotics 7 days after onset of bacteremia in hematologic disease patients with bacteremic neutropenic fever after chemotherapy (n=174)

Empirical antibiotics N (%) Negative blood culture (%) Improved CRP (%) Resolution of fever (%) Early response failure (%)
Ceftizoxime/amikacin 81 (46.6%) 98.8 84.0 81.5 18.5
Piperacillin/ tobramycin 40 (22.9%) 100 85.0 87.5 25.0
Piperacillin/ tazobactam 32 (18.4%) 96.9 90.6 78.1 21.9
Meropenem 12 (6.9%) 100 83.3 75.0 25.0
Others† 9 (5.2%) 88.9 77.8 77.8 22.2

CRP; C-reactive protein

*Cefepime, colistin, vancomycin.

J. Kor. Soc. Health-syst. Pharm. 2021;38:319-30 https://doi.org/10.32429/jkshp.2021.38.3.003
© 2021 J. Kor. Soc. Health-syst. Pharm.